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1. Introduction
Development of postnatal new blood vessels occurs essentially by two temporally distinct
but interrelated processes, vasculogenesis and angiogenesis. Vasculogenesis is the process of
blood vessel formation occurring by a de novo production of endothelial cells in an embryo
(primitive vascular network) or a formerly avascular area when endothelial precursor cells
(angioblasts, hemangioblasts or stem cells) migrate and differentiate in response to local
cues (such as growth factors and extracellular matrix) to form new intact blood vessels (Ri‐
sau and Flamme, 1995). Angiogenesis refers principally to the sprouting of new blood ves‐
sels from the differentiated endothelium of pre-existing vessels. These vascular trees or
plexuses are then pruned, remodeled and extended through angiogenesis to become larger
caliber vessels (Carmeliet, 2000). In addition, there exists yet another unique mechanism of
neovascularization, the postnatal vasculogenesis, where new blood vessels are formed by
the process of fusion and differentiation of endothelial progenitors of bone marrow origin
(Valarmathi et al., 2009). This indicates a potential role for bone marrow-derived progenitor
cells in postnatal neovasculogenesis and/or neoangiogenesis. This implies that additional
mechanisms besides angiogenesis can occur in the adult, and has opened up the possibility
to investigate the embryonic origin and development of these putative progenitor cells.
The adult bone marrow contains two subsets of multipotential stem cells, hematopoietic
stem cells (HSCs) and bone marrow stromal cells or mesenchymal stem cells (BMSCs/
MSCs). BMSCs are a readily available heterogeneous population of cells that can be directed
to differentiate into multiple mesenchymal and non-mesenchymal cells either in vitro or in
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vivo (Wakitani et al., 1995; Pittenger et al., 1999; Makino et al., 1999; Fukuda et al., 2001;
Bianco et al., 2001; Valarmathi et al., 2009; 2010). Most noticeably, BMSCs have been induced
to undergo maturation and differentiation towards vascular endothelial and smooth muscle
cell lineages. Previous reports indicate that BMSCs and bone marrow-derived multipotent
adult progenitor cells (MAPCs) can be differentiated into endothelial-like cells in vitro and
contribute to neoangiogenesis in vivo (Oswald et al., 2004; Reyes et al., 2002; Al-Khaldi et al.,
2003). Additionally, it has been shown that BMSCs can augment collateral remodeling and
perfusion in ischemic models through paracrine mechanisms rather than by cellular incor‐
poration upon local delivery (Kinnaird et al., 2004). Therefore, the identification of bone-
marrow-derived (hematopoietic and non-hematopoietic stem cells) and non-bone-marrow-
derived (tissue-resident stem/progenitor cells – adipose, neural, heart, skeletal muscle;
peripheral and cord blood-derived stem cells) endothelial progenitors cells (EPCs) has led to
the realization of potential postnatal vasculogenesis (Urbich and Dimmeler, 2004).
A variety of cellular types can be mobilized from the bone marrow reservoir and can home
to sites of neovascularization, where they enhance the angiogenic process (Bertolini et al.,
2006). While the concept that vascular progenitors are delivered and recruited was initially
conceived and based on the circulating endothelial stem/progenitors (EPCs) paradigm, cur‐
rently, it has become obvious that other classes of vasculogenic cells can also be derived
from the in situ de novo differentiation of precursor cells. Among these, a population of Tie2
expressing mesenchymal precursor cells was recently identified, which are capable of in vi‐
tro expansion and of generating Tie2 negative but α-SMA positive cells when re-introduced
into the tumors (De Palma et al., 2005). On the one hand, the mechanism by which these
cells (EPCs) are recruited from the bone marrow to sites of new blood vessel formation re‐
mains an area of active study, but on the other hand, the mechanisms of by which EPCs
egress from the bone marrow and subsequent recruitment to sites of neovascularization/
neoangiogenesis warrants further investigation.
Even though there exists ample evidence for the existence of EPCs, proof of a functional re‐
quirement for EPCs mobilization and vascular recruitment in human cancer necessitates fur‐
ther experimentation. In addition, to address the temporal as well as spatial contribution of
not only these EPCs but also other marrow-derived stem/progenitors to a specific tumor en‐
vironment require the generation of novel tumor model systems. And these model systems
can be utilized to evaluate the subtle contribution of marrow-derived stem/progenitors dur‐
ing the early phases of the neo-angiogenic switch besides oncogenic transformation.
For the above mentioned reasons, embryonic, fetal and postnatal stem cells as well as vari‐
ous types of progenitor cells, can be a potential cellular source for vascular tissue engineer‐
ing (Levenberg, 2005). However, the source for the early-stage developmental cells is
restricted. The utility of embryonic stem cells (ESCs) and induced pluripotent stem cells
(iPSCs) in facilitating vascularized tissue/organ regeneration is still in its incipient stages. A
number of issues, including a propensity for some implanted ESCs/iPSCs to form benign
teratomas and/or malignant teratocarcinomas in the regenerating tissue/organ, remain to be
addressed. In contrast to both ESCs/iPSCs, it has been well established that the adult stem
cell, BMSCs exhibit multilineage differentiation potential in a well-controlled, predictable
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fashion. Moreover, unlike ESCs derivation, obtaining autologous or allogeneic BMSCs is fea‐
sible and can potentially be exploited to develop tissue-engineered blood vessel constructs
for therapeutic purposes. Similarly, when compared to bone marrow-derived BMSCs, re‐
peated isolation and rapid expansion of sufficient yield of autologous and/or allogeneic non-
bone-marrow-derived resident stem cells/progenitors, especially from vital organs for
routine therapeutic purposes are highly constrained. On the contrary, to a certain extent, au‐
tologous and/or allogeneic bone marrow-derived BMSCs are amenable for repeated isola‐
tion and reasonable in vitro expansion from the patients. In addition, the significant
advantage of using these BMSCs is their low immunogenicity. And these autologous or allo‐
geneic BMSCs have been reported to be immunomodulatory and immunotolerogenic both
in vitro as well as in vivo. (Aggarwal and Pittenger, 2005). Taken together, these data strong‐
ly indicate that BMSCs can represent the potential cell of choice for adult autologous and/or
allogeneic stem cell based vascularized tissue regeneration.
Extracellular molecules initiate biological signals and play a critical role in the control of cellu‐
lar proliferation, differentiation, and morphogenesis. Many parameters, such as the presence
and amount of soluble factors such as hormones, growth factors, and cytokines or the insolu‐
ble factors such as the physical configuration of the matrix which mediates the cell-cell interac‐
tions  and cell-matrix  interactions,  exert  a  strong influence  on  the  success  of  angiogenic
processes in vitro and presumably in vivo (Even-Ram and Yamada, 2005; Carlson, 2007). The
likelihood and ultimate success of in vitro cellular differentiation depends on how closer the
cell-matrix interactions and relationships’ mimic to those found during normal development
or regeneration. In vascular tissue engineering, the application of these principles in vivo will
be important to ensure that the matrix/scaffold to be implanted can support endothelial cell
proliferation and migration resulting in endothelial tube formation (Ingber and Folkman,
1989). The vital issue for realistic clinical application is whether these scaffolds with pre‐
formed network of endothelial capillaries/microvessels can survive implantation into tissue
defects and subsequently be able to anastomose to the host vasculature.
We therefore hypothesized that under appropriate in vitro physicochemical microenviron‐
mental cues (combination of growth factors and extra cellular matrix, ECM) multipotent
adult BMSCs could be differentiated into vascular endothelial and smooth muscle cell line‐
ages. To test this hypothesis, we characterized the intrinsic vasculogenic differentiation po‐
tential of adult BMSCs when seeded onto a three-dimensional (3-D) tubular scaffold
engineered from aligned type I collagen strands and cultured in both vasculogenic and non-
vasculogenic growth media. In these culture conditions, BMSCs differentiated and matured
into both endothelial and smooth muscle/pericyte cell lineages and showed microvascular
morphogenesis. We also explored the potential of the 3-D model system to undergo postna‐
tal de novo vasculogenesis.
2. Experimental approach
The differentiation of rat BMSCs was carried out on a 3-D tubular scaffold made up of
aligned type I collagen-gel fibers. Rat BMSCs were isolated from the tibial and femoral bone
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marrow of adult rats. The BMSCs isolated from the bone marrow were expanded, main‐
tained and passaged to make sure that the attached marrow stromal cells were devoid of
any non-adhering populations of cells. Phenotypic characterization of the BMSCs for cell
surface markers was performed by confocal microscopy (qualitative evaluation) and single-
color flow cytometry (quantitative analysis). This adherent population of cells was further
purified and enriched by indirect magnetic cell sorting. The cells were subjected to CD90
positive selection. The resultant enriched CD90+/CD34-/CD45- fractions were expanded by
subculturing and subjected to flow cytometric analysis to validate the proper phenotype.
This population of purified BMSCs was used in all experiments. For vasculogenic differen‐
tiation of BMSCs, the expanded and purified population of CD90+ BMSCs were seeded into
the collagen-gel tubular scaffold and cultured either in vasculogenic or non-vasculogenic
culture medium for 28 days. At regular intervals of 7, 14, 21 and 28 days the tube cultures
were assayed by RT-qPCR, immunofluorescence, ultrastructural and biochemical analyses
for various endothelial and smooth muscle differentiation markers as shown in table 1, 2
and 3. The time points at which these analyses were carried out cover the optimal range of
both vasculogenesis and angiogenic processes seen in vivo and/or in vitro and mimic the
progression of microvascular development.
3. Research methods
3.1. Fabrication of tubular scaffold
The 3-D collagen type I tube served as a scaffold on which rat BMSCs differentiation cul‐
tures were carried out (Figure 1). The details of the production and properties of the col‐
lagen  tubular  scaffolds  have  previously  been  described  (Yost  et  al.,  2004).  Briefly,  a  25
mg/ml solution of bovine collagen type I was extruded with a device that contained two
counter-rotating  cones.  The  liquid  collagen  was  fed  between  the  two  cones  and  forced
through a  circular  annulus  in  the  presence  of  an  NH3-air  (50-50  vol/vol)  chamber.  This
process results in a hollow cylindrical tube of aligned collagen fibrils with an inner cen‐
tral lumen. The dimensions of tubes produced for this set of experiments had a length of
30 mm with a luminal  diameter of  4  mm and an external  diameter of  5  mm, leaving a
wall thickness of 0.5 mm. The collagen tubes had a defined fiber angle of 18° relative to
the central axis of the tube and had pores ranging from 1 to 10 μm. The rationale for the
particular orientation of collagen fibers was based on our previous work on cardiovascu‐
lar tissue engineering (Yost et al.,  2004). When proepicardial organ (PE) cells were seed‐
ed  onto  this  scaffold,  they  underwent  maturation  and  differentiation  and  produced
elongated vessel-like structures reminiscent  of  in vivo-like phenotype (Valarmathi  et  al.,
2008). The tubes were sterilized using gamma radiation 1200 Gy followed by Stratalinker
UV crosslinker  1800 (Stratagene)  and then placed in  Mosconas’s  solution (in  mM: 136.8
NaCl,  28.6  KCl,  11.9  NaHCO3,  9.4  glucose,  0.08  NaH2PO4,  pH 7.4)  (Sigma-Aldrich)  con‐
taining 1 μl/ml gentamicin (Sigma-Aldrich) and incubated in 5% CO2  at 37°C until cellu‐
lar seeding (Valarmathi et al., 2010).
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Figure 1. Fabrication of 3-D collagen gel based tubular scaffolds engineered from aligned type I collagen fibers. Type I
collagen was extracted from bovine calf hides (A). Bovine collagen type I was extruded with a device that contained
two counter-rotating cones to generate the 3-D collagen gel tubular scaffolds. The dimensions of tubes produced for
this set of experiments had a length of 30 mm with a luminal diameter of 4 mm and an external diameter of 5 mm,
leaving a wall thickness of 0.5 mm. The collagen tubes had a defined fiber angle of 18° relative to the central axis of
the tube and had pores ranging from 1 to 10 μm (B). (A and B, courtesy of M.J. Yost)
3.2. BMSCs isolation, expansion and maintenance
The initial  step is  to  isolate  the mononuclear  cells  from the bone marrow by aspiration
and centrifugation followed by plating and isolation of the cells based on differential ad‐
herence capacity to tissue culture dishes (passage 0 cells). Rat BMSCs were isolated from
the bone marrow of  adult  300g Sprague Dawley®™ SD®™ rats  (Harlan Sprague Daw‐
ley, Inc.). Briefly, after deep anesthesia, the femoral and tibial bones were removed asep‐
tically and cleaned extensively to remove associated soft connective tissues. The marrow
cavities  of  these  bones  were  flushed with  Dulbecco’s  Modified Eagle  Medium (DMEM;
Invitrogen)  and  combined.  The  isolated  marrow  plugs  were  triturated,  and  passed
through needles  of  decreasing  gauge  (from 18  gauge  to  22  gauge)  to  break  up clumps
and  cellular  aggregates.  The  resulting  single-cell  suspensions  were  centrifuged  at  200g
for 5 minutes. Nucleated cells were counted using a Neubauer chamber. Cells were plat‐
ed at a density of 5 X 106  – 2 X 107  cells per T75 cm2  flasks in basal media composed of
DMEM supplemented with 10% fetal bovine serum (FBS, lot-selected; Hyclone), gentami‐
cin  (50  μg/ml)  and  amphotericin  B  (250  ng/ml)  and  incubated  in  a  humidified  atmos‐
phere of 5% CO2 at 37°C for 7 days. The medium was replaced, and changed three times
per week until the cultures become ~70% confluent (between 12 and 14 days). Cells were
trypsinized using 0.05% trypsin-0.1% EDTA and re-plated at a density of 1 x 106 cells per
T75 cm2  flasks.  After three passages,  attached marrow stromal cells  were devoid of any
non-adhering population of cells. These passaged BMSCs were cryopreserved and stored
in liquid nitrogen until further use (Valarmathi et al., 2011).
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3.3. Immunophenotyping of BMSCs by flow cytometry and confocal microscopy
BMSCs are a heterogeneous population of cells with varying degrees of cell shapes and sizes
(Anokhina et al., 2007). Stringent characterization of BMSCs used in experimental proce‐
dures is required for various cell surface markers; this is to ensure that the employed popu‐
lation of cells contains solely stem/progenitor cells. This will obviate the possible
contamination of marrow-derived endothelial cells and macrophages that are part of the ad‐
herent population of cultured cells. Therefore, characterization of BMSCs included qualita‐
tive evaluation for various cell surface markers and was performed on cells grown in the
Lab-tekTM chamber slide systemTM (Nunc) using a Zeiss LSM 510 Meta confocal scanning la‐
ser microscope (Carl Zeiss, Inc.), and quantitative analysis of the same set of markers was
performed by single-color flow cytometry using a Coulter® EPICS® XL™ Flow Cytometer
(Beckman Coulter, Inc.) as previously described (Valarmathi et al., 2009).
Criteria to Identify BMSCs/MSCs
1. Adherence to plastic in standard culture conditions
2. Phenotype Positive (≥95%+)
CD73
CD90
CD105
Negative (≤2%+)
CD11b or CD14
CD34
CD45
CD79α or CD19
HLA-DR
3. In vitro differentiation: Osteoblasts, Chondroblasts and Adipocytes.
(Demonstrated by staining of in vitro cell culture)
International Society for Cellular Therapy (ISCT): Mesenchymal and Tissue Stem Cell Committee
Table 1. Criteria to identify BMSCs/MSCs (Dominici et al., 2006)
Immunophenotyping of passage 3 undifferentiated BMSCs for various cell surface mark‐
ers by flow cytometry revealed that the fluorescent intensity and distribution of the cells
stained for CD11b, CD31, CD34, CD44, CD45 and CD106 were not significantly different
from the intensity  and distribution of  cells  stained with isotype controls  (Figure  2  A-E,
H). In addition, these cells were negative for the rat endothelial cell surface marker OX43
(Figure 2, I),  an antigen expressed on all vascular endothelial cells of rat, indicating that
these cultures were devoid of any possible hematopoietic stem and/or progenitor cells as
well as differentiated bone-marrow-derived endothelial cells.  In contrast,  BMSCs exhibit‐
ed high expression of CD73 and CD90 surface antigens (Figure 2, F-G), which is consis‐
tent with their  undifferentiated state.  Furthermore,  flow cytometric  analysis  of  the same
passage 3 BMSCs for various other vascular endothelial cell surface antigens and smooth
muscle  cell  intracellular  antigens  revealed  that  these  cells  were  negative  for  Flt1,  Flk1
and VE-cadherin (Figure 2, J-L) and, were predominantly positive for calponin (Figure 2,
M). The expression profiles of these surface molecules were consistent with previous re‐
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ports and the minimal criteria for defining multipotent mesenchymal stromal cells, enun‐
ciated  by  the  international  society  for  cellular  therapy  (ISCT)  position  statement
(Valarmathi et al., 2009; Reyes et al., 2002; Dominici et al., 2006).
Phenotypic characterization using the same set of markers on passage 3 BMSCs by confocal
microscopy also revealed that the cells were negative for CD11b, CD31, CD34, CD44, CD45
and OX43 (Figure 3, A-J, O-P), and strongly positive for CD73 and CD90 (Figure 3, K-N).
The permeabilized cells when stained for Vcam1 (CD106), Flt1 (Vegfr1), Flk1 (Vegfr2) and
VE-cadherin (Figure 4, A-H) revealed faintly detectable cytoplasmic and/or nuclear signal of
these endothelial antigens. While these cells showed abundant cytoplasmic expression of
smooth muscle antigen, calponin (Figure 4, I-J). Phenotypic characterization and evaluation
of these markers on clonally expanded BMSCs showed similar expression patterns consis‐
tent with their parent culture.
Primary Antibodies Dilutions Source Cell Target
BMSCs characterization markers
CD11b 1:50 BD Pharmingen Leukocytes
CD31 1:10 Abcam Endothelial
CD44 1:10 Gene Tex, Inc Leukocytes
CD45 1:50 BD Pharmingen Hematopoietic
CD73 1:50 BD Pharmingen BMSCs
CD90 1:50 BD Pharmingen BMSCs
CD106 1:50 BD Pharmingen Endothelial
OX43 1:10 Gene Tex, Inc Endothelial
Endothelial cell differentiation markers
CD34 1:100 Santa Cruz Biotechnology Endothelial
Flt-1 1:100 Santa Cruz Biotechnology Endothelial
Flk-1 1:100 Santa Cruz Biotechnology Endothelial
VE- cadherin 1:100 Santa Cruz Biotechnology Endothelial
Pecam1 1:100 Santa Cruz Biotechnology Endothelial
Vwf 1:100 Santa Cruz Biotechnology Endothelial
Tomato lectin 1:50 Vector Laboratories Endothelial
Fibronectin 1:200 Abcam Endothelial
Smooth muscle cell differentiation markers
α-SMA 1:100 Sigma-Aldrich Smooth Muscle
Calponin 1:5000 Sigma-Aldrich Smooth Muscle
Table 2. Primary antibodies used in this study (Valarmathi et al., 2009).
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Figure 2. Immunophenotyping of passage 3 undifferentiated rat BMSCs by flow cytometry. Single parameter histo‐
grams showing the relative fluorescence intensity of staining (abscissa) and the number of cells analyzed, events (ordi‐
nate). Isotype controls were included in each experiment to identify the level of background fluorescence. The
intensity and distribution of cells stained for hematopoietic and endothelial markers; CD11b, CD31, CD34, CD44,
CD45, CD106, OX43, Flt-1, Flk-1 and VE-cadherin (green, shaded peaks) were not significantly different from those of
isotype control (red, open peaks) (Panels A-E, H-L). The fluorescent intensity was greater (shifted to right) when BMSCs
were stained with CD73, CD90 and calponin (green) compared to isotype control (red) (Panels F, G, M). The predomi‐
nant population of BMSCs uniformly expressed CD90 surface molecule, consistent with their undifferentiated state.
Adapted from Valarmathi et al., 2009.
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Figure 3. Immunophenotyping of passage 3 undifferentiated rat BMSCs by confocal microscopy. Phenotypic charac‐
terization and evaluation revealed that the permeabilized cells were negative for CD11b, CD31, CD34, CD44, CD45
and OX43 (Figure 3, A-J, O-P), indicating that these cultures were devoid of any potential hematopoietic and/or endo‐
thelial cells of bone marrow origin. However, the cells consistently expressed both CD73 and CD90 (Figure3, K-N) sur‐
face antigens, a property of mesenchymal/stromal stem cells. Isotype controls were included in each experiment to
identify the level of background staining. Cells were also stained for nuclei (blue, DAPI) and fibrillar actin (red, rhoda‐
mine phalloidin). Merged images (B, D, F, H, J-N, P). (A-P, scale bar 100 μm). Adapted from Valarmathi et al., 2009.
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Figure 4. Confocal microscopic analysis of various vascular related antigens on passage 3 undifferentiated rat BMSCs.
Evaluation of the permeabilized cells for Vcam1 (CD106), Flt1 (Vegfr1), Flk1 (Vegfr2) and VE-cadherin revealed faintly
detectable cytoplasmic and/or nuclear signals of these endothelial antigens (Figure 4, A-H). Whereas, these cells
showed abundant cytoplasmic expression of smooth muscle antigen, calponin (Figure 4, I-J). Suggesting that BMSCs
constitutively express very low-levels of endothelial associated antigens as well as very high-levels of smooth muscle
specific antigens. Isotype and/or negative controls were included in each experiment to identify the level of back‐
ground staining. Cells were also stained for nuclei (blue, DAPI) and fibrillar actin (red, rhodamine phalloidin). Merged
images (B, D-F, H-J). (A-J, scale bar 100 μm). Adapted from Valarmathi et al., 2009.
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3.4. Purification and enrichment of CD90+ BMSCs by Magnetic-Activated Cell Sorting
(MACS)
Purification and enrichment of input BMSCs (such as CD45-, CD34-, CD105) are manda‐
tory  either  using  MACS  (magnetic  activated  cell  sorter)  or  FACS  (fluorescent  activated
cell  sorter).  Since  the  unpurified  fraction  may contain  sizable  number  of  contaminating
adherent  macrophages and bone marrow-derived endothelial  progenitors  and differenti‐
ated endothelial cells. The adherent populations of BMSCs were further purified by indi‐
rect  magnetic  cell  labeling  method  using  an  autoMACS™  Pro  Separator  (Miltenyi
Biotech). The cells were subjected to CD90 positive selection by incubating the cells with
FITC- labeled anti-CD90 antibodies (BD Pharmingen),  followed by incubation with anti-
FITC magnetic microbeads (Miltenyi Biotech), and passed through the magnetic columns
as  per  the  manufacturer’s  instructions.  The  resultant  enriched  CD90+/CD34-/CD45-  frac‐
tions were expanded by subcultivation and subjected to flow cytometric  analysis  as  de‐
scribed previously (Valarmathi et al., 2010).
3.5. BMSCs vasculogenic differentiation
For vasculogenic differentiation of BMSCs, the purified population of CD90+ BMSCs were
seeded into the collagen-gel tubes at a density of 0.5 x 106 cells/30 mm tube lengths and cul‐
tured either in mesenchymal stem cell growth medium supplemented with 10% FBS, peni‐
cillin and streptomycin (Poietics® MSCGM™ BulletKit®; Lonza Ltd.) or microvascular
endothelial cell growth medium (Clonetics® EGM®-MV Bullet Kit®; Lonza Ltd.) supplement‐
ed with 5% FBS, bovine brain extract, human epidermal growth factor (hEGF), hydrocorti‐
sone, amphotericin B and gentamicin for 28 days. These BMSCs seeded tubes were cultured
either in vasculogenic or non-vasculogenic medium for the defined time periods of 7, 14, 21
and 28 days. In addition, BMSCs were seeded in 65-mm Petri dishes at a density of 3 x 103
cells/cm2 and cultured in non-vasculogenic (MSCGM) or vasculogenic (EGMMV) media for
7, 14, 21 and 28 days.
4. BMSCs based postnatal de novo vasculogenesis and in situ vascular
regeneration
The 3-D collagen-gel tubular scaffold has previously been used to create models of vascular‐
ized bone development (Valarmathi et al., 2008a; 2008b). Here we report the utility of a 3-D
tubular construct for its ability to support the vasculogenic differentiation of BMSCs culmi‐
nating into microvascular structures, which are similar to those structures resulting from
postnatal de novo vasculogenesis and angiogenesis (Valarmathi et al., 2008a; 2008b).
In the developing vertebrate embryo, the initial event of blood vessel formation is the differ‐
entiation of vascular endothelial cells, which subsequently cover the entire interior surface
of all blood vessels. Angioblasts are a subpopulation of primitive mesodermal cells that are
committed to differentiate into endothelial cells and later on form the primitive vascular lab‐
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yrinth (Risau and Flamme, 2000). In addition, endothelial cells can also arise from heman‐
gioblasts, a common precursor for both hematopoietic and endothelial cells (His et al., 1900).
In adults, endothelial precursor cells have been identified in bone marrow, peripheral blood
and blood vessels (Prater et al., 2007). Two subsets of multipotential stem cells, HSCs and
BMSCs/MSCs are resident in the postnatal bone marrow. Of these cells, BMSCs can be dif‐
ferentiated into osteoblasts, chondrocytes, adipocytes, smooth muscle cells and hemato‐
poietic supportive stroma either in vitro or in vivo (Bianco et al., 2001). Previous studies
have provided substantial evidence that bone-marrow-derived stem and/or progenitor cells
can be differentiated into either endothelial or smooth muscle cells in vitro and in pathologi‐
cal situations are capable of contributing to neoangiogenesis in vivo by cellular integration
(Carmeliet and Luttun, 2001).
Although there are a plethora of studies focused on developing viable scaffolds for osteo‐
genic, chondrogenic, adipogenic and musculogenic differentiation of BMSCs (Lanza et al.,
2000), the optimal scaffolds that are capable of inducing and supporting the growth and dif‐
ferentiation of BMSCs into vascular cell lineages are yet to be identified and characterized.
Despite the much known vasculogenic potential and transgermal plasticity of BMSCs; none
of these studies explicitly demonstrated the postnatal de novo vasculogenic potential of
BMSCs in vitro (Reyes et al., 2002; Oswald et al., 2004; Brey et al., 2005).
When compared to 2-D planar cultures, the potential 3-D models of vasculogenesis allow us
to understand the role of specific factors under more physiological and spatial conditions
with respect to dimensionality, architecture and cell polarity. Nevertheless, the molecular
composition and the natural complexity and diversity of in vivo extra cellular matrix (ECM)
organization cannot be easily mimicked or reproduced in vitro (Vailhe et al., 2001). In addi‐
tion, even though quite a few in vitro 3-D models of vasculogenesis based on fibrin and col‐
lagen gels are in vogue (Folkman and Haudenschild, 1980); none have explored the
behavior of BMSCs and their intrinsic vasculogenic differentiation potential on a topograph‐
ically structured 3-D tubular scaffold made of uniformly aligned type I collagen fibers.
Previous studies demonstrated that the formation of endothelial tubes in vitro was largely
influenced by the nature of the substrate (Kleinman et al., 1982). The formation of endotheli‐
um lined tubular structures was enhanced when the substrate was rich in laminin (Madri et
al., 1988), whereas a matrix rich in type I collagen would not promote rapid tubulogenesis
(Montesano et al., 1983; Ingber and Folkman, 1989). Similarly, Ingber and Folkman (1989)
documented that under a given cocktail of growth factors, the local physical nature of the
interaction between endothelial cells and the underlying matrix/substrate ultimately deter‐
mined the tubular morphogenesis. Substrates containing abundant fibronectin promoted
adhesion, spreading and growth of endothelial cells. In contrast, less adhesive substrate or
matrix materials that were arranged three-dimensionally permitted the endothelial cells to
retract and form tubes (Ingber and Folkman, 1989).
In general, successful in vitro differentiation of cells depends on cell-cell as well as cell-ma‐
trix interactions. Therefore, we hypothesized that under appropriate in vitro local environ‐
mental cues (combination of growth factors and ECM) multipotent postnatal BMSCs could
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be induced to undergo microvascular development. Hence, we developed a 3-D culture sys‐
tem in which a pure population of CD90+ rat BMSCs was seeded and cultured on a highly
aligned, porous, biocompatible collagen-fiber tubular scaffold for differentiation purposes.
Here, we utilized two types of growth media for vasculogenic differentiation purpose,
MSCGM (non-vasculogenic) as control and EGMMV (vasculogenic) preferentially for micro‐
vascular differentiation. Both of these culture media consistently promoted the vasculogenic
differentiation of BMSCs and also supported the formation of endothelium lined vessel-like
structures within the constructs.
A number of early and late stage markers associated with rodent vascular development in
vivo were used in this study to characterize the rat BMSCs derived microvascular structures
at mRNA and protein levels, which included: CD31/Pecam1, Flt1 (Vegfr1), Flk1 (Vegfr2/
Kdr), VE-cadherin (CD144), CD34, Tie1, Tek (Tie2), and Von Willibrand factor (Vwf). Plate‐
let/endothelial cell adhesion molecule, also known as CD31, is a transmembrane protein ex‐
pressed abundantly early in vascular development that may mediate leukocyte adhesion
and migration, angiogenesis, and thrombosis (Albelda et al., 1991). The other early stage dif‐
ferentiation markers Flk1 and Flt1 that are receptors for the vascular endothelial cell growth
factor-A (Vegf) essentially play a vital role in embryonic vascular and hematopoietic devel‐
opment (Shalaby et al., 1997). Similarly, VE-cadherin, a member of the cadherin family of
adhesion receptors, is a specific and constitutive marker of endothelial cell plays an impor‐
tant role in early vascular assembly. Vascular markers that are expressed at a later stage in‐
clude CD34 and Tie-2 (Bautch et al., 2000). CD34 is a transmembrane surface glycoprotein
that is expressed in endothelial cells and hematopoietic stem cells. Tie1 and Tek are receptor
kinases on endothelial cells that are essential for vascular development and remodeling in
the embryo and may also mediate maintenance and repair of the adult vascular system. In
late phases of vasculogenesis, the mature endothelial cells will synthesize and secrete Vwf
homolog, a plasma protein that mediates platelet adhesion to damaged blood vessels and
stabilizes blood coagulation factor VIII.
Genes Forward primer Reverse primer Product
length
(bp)
Annealing
temperature
(°C)
GenBank accession
No
Pecam1 5’–CGAAATCTAGGCCTCAGCAC–3’ 5’–CTTTTTGTCCACGGTCACCT–3’ 227 56 NM_03159.1
Kdr 5’–TAGCGGGATGAAATCTTTGG–3’ 5’–TTGGTGAGGATGACCGTGTA–3’ 207 56 NM_013062.1
Tie1 5’–AAGGTCACACACACGGTGAA–3’ 5’–TGGTGGCTGTACATTTTGGA–3’ 174 56 XM_233462.4
Tek 5’–CCGTGCTGCTGAACAACTTA–3’ 5’–AATAGCCGTCCACGATTGTC–3’ 201 56 NM_001105737.1
Vwf 5’–GCTCCAGCAAGTTGAAGACC–3’ 5’–GCAAGTCACTGTGTGGCACT–3’ 163 56 XM_342759.3
Gapdh 5’–TTCAATGGCACAGTCAAGGC–3’ 5’–TCACCCCATTTGATGTTAGCG–3’ 101 56 XR_007416.1
Table 3. RT-qPCR primer sequences used in this study (Valarmathi et al., 2009; Rozen and Skaletsky, 2000).
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In any type of in vitro cellular differentiation, the cytodifferentiated cells need to be critically
evaluated for their maturation and differentiation at transcriptional, translational and func‐
tional levels. Therefore, to study the expression pattern of key vasculogenic gene transcripts in
the 3-D tube constructs; we examined the time-dependent expression pattern of Pecam1, Kdr,
Tie1, Tek and Vwf at mRNA level in the tube constructs by real-time PCR (Figure 5 A-D).
Figure 5. Real-time reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) analysis of various key vas‐
culogenic markers, platelet/endothelial cell adhesion molecule 1 (Pecam1), kinase insert domain protein receptor
(Kdr/Flk1/Vegfr-2), tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (Tie1), endothelial-specific re‐
ceptor tyrosine kinase (Tek/Tie2) and Von Willebrand factor homology (Vwf) as a function of time (abscissa). BMSCs
cultured in Petri dishes (2-D culture) in mesenchymal stem cell growth medium (A) and, in microvascular growth medi‐
um (B). BMSCs cultured in collagen-gel tubular scaffolds (3-D culture) in mesenchymal stem cell growth medium (C)
and, in microvascular growth medium (D). The calibrator control included passage 4 BMSCs day 0 sample and; the
target gene expression was normalized by a non-regulated reference gene expression, Gapdh. The expression ratio
(ordinate) was calculated using the REST-XL version 2 software (Pfaffl 2001; Pfaffl et al., 2002). The values are means ±
standard errors for three cultures (n=3), *p<0.005; **P<0.001. Adapted from Valarmathi et al., 2009.
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Constitutive expressions of these markers were detected at low to very low levels in undif‐
ferentiated BMSCs. RT-qPCR results showed that differentiation of BMSCs under vasculo‐
genic culture conditions for 28 days resulted in increased expression of transcripts coding
for various endothelial cell associated proteins such as Pecam1, Kdr, Tek and Vwf. The peak
expression of Vwf, the endothelial specific protein occurred around day 21 (over 400 fold)
indicating that the differentiating cells acquired a distinctive phenotype and biosynthetic ac‐
tivity of differentiated and matured endothelial cells. The upregulation of Tek during this
period may represent the continual development and remodeling of the developing micro‐
vessels. Whereas differentiation of BMSCs under non-vasculogenic conditions for 14 days
showed signs of early and rapid induction of transcripts coding for both early and late stage
endothelial cell markers such as Kdr, Tie1, Tek and Vwf. The peak expression of Vwf occur‐
red during day 14 (over 20 fold).
As revealed by immunostaining for various vasculogenic markers, day 21 vasculogenic and
non-vasculogenic tube cultures showed that BMSCs were able to adhere, proliferate, migrate
and, undergo complete maturation and differentiation into microvascular structures (Figure 6
A-C). BMSCs derived microvessel formation is a combination of de novo vasculogenesis i.e., in
situ endothelial cell differentiation and endothelium-lined tube formation, and angiogenesis,
endothelial sprouting from existing endothelial tubes. In addition, these microvessels are stabi‐
lized by association with BMSC-derived smooth muscle cells and/or pericytes.
Figure 6. Localization of BMSCs derived endothelial cells by Texas Red labeled Lycopersicon Esculentum lectin/Toma‐
to Lectin (LEL/TL) staining. BMSCs cultured in collagen-gel tubular scaffolds in both vasculogenic and non-vasculogen‐
ic culture conditions were incubated with tomato lectin (1:50 in 10 mM N-2-hydroxyethylpiperazine-N’-2-
ethanesulfonic acid, pH 7.5; 0.15 M NaCl), and was used to identify endothelial cells. Confocal laser scanning
microscopic analysis of sections of day 14 tubular scaffolds in these media conditions demonstrated the typical cob‐
blestone appearance of differentiating endothelial cells (A), fusion and self-assembly (B), and evolving primitive capil‐
lary plexus with attempted lumen formation (B-C, white arrows). Cells were also stained for nuclei (blue, DAPI). Image
(A) shows a projection representing 19 sections collected at 5.05 μm intervals (90.90 μm). Image (B) shows a projec‐
tion representing 13 sections collected at 4.05 μm intervals (48.60 μm). Image (C) shows a projection representing 15
sections collected at 6 μm intervals (84.00 μm). Merged images (A-C). (A-B, scale bar 100 μm; C, scale bar 50 μm).
To validate the findings of mRNA expression pattern of important vasculogenic markers in
these tube cultures and to determine whether these messages were in fact translated into pro‐
teins, immunostaining of the BMSC tube culture was carried out (Figure 7 A-L; Figure 8 A-L).
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Figure 7. Expression pattern of various vasculogenic markers in tubular scaffold by confocal microscopy. Localization
of key endothelial and smooth muscle cell phenotypic markers of day 21 non-vasculogenic tube cultures demonstrat‐
ed the expression of CD34 (A-C), Pecam1 (D-F), Vwf (G-I), VE-cadherin (J-L) and α-SMA (B-C, E-F, H-I, K-L). Dual immu‐
nostainings of non-vasculogenic tube cultures (mesenchymal stem cell growth media, MSCGM) revealed areas of
elongated and flattened cells composed of varying degrees of mature endothelial and smooth muscle cells (A-L).
These cells were organized into a loose delicate network of nascent capillary-like structures composed of mature en‐
dothelial and smooth muscle cells and showed evidence of central lumen formation (white arrows, D-I). In addition,
tube-like structures were emanating from the mixed population of vasculogenic cells represented by their distinct
morphology and phenotypic expression (white arrows, A-C; white arrows, J-L). Cells were also stained for nuclei (blue,
DAPI). Images (A-C) show a projection representing 15 sections collected at 5.05 μm intervals (70.70 μm). Images (D-F)
show a projection representing 19 sections collected at 5.05 μm intervals (90.90 μm). Images (J-L) show a projection
representing 19 sections collected at 4.04 μm intervals (72.90 μm). Merged images (A-L). (A-L, scale bar 50 μm).
Adapted from Valarmathi et al., 2009.
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Figure 8. Expression pattern of various vasculogenic markers in tubular scaffold by confocal microscopy. Localization
of key endothelial and smooth muscle cell phenotypic markers of day 21 vasculogenic tube cultures demonstrated the
expression of Flk1 (A, C), VE-cadherin (D, F), Vwf (G, I; J, L), tomato lectin (E-F; H-I) and α-SMA (B-C, K-L). Dual immunos‐
tainings of vasculogenic tube cultures (microvascular endothelial growth medium, EGMMV) revealed areas of elongat‐
ed cells composed of both mature endothelial and smooth muscle cells (A-L). These cells formed developing
microvessl-like structures (A-F, J-L). The linear nascent capillary-like structures showed a translucent central lumen
(white arrows, D-F). In addition, the cells were organized into a loose network of vascular cells and were in a ribbon-
like configuration (G-I). These aligned vascular cells transformed into thin tube-like structures reminiscent of in vivo
microvessel morphogenesis (J-L). Cells were also stained for nuclei (blue, DAPI). Images (D-F) show a projection repre‐
senting 13 sections collected at 3.05 μm intervals (36.60 μm). Images (G-I) show a projection representing 18 sections
collected at 7.05 μm intervals (119.8 μm). Images (J-L) show a projection representing 27 sections collected at 6.05 μm
intervals (157.3 μm). Merged images (A-L). (A-C, J-L scale bar 100 μm; D-F, G-I scale bar 50 μm). Adapted from Valar‐
mathi et al., 2009.
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It  is  well  known that  endothelial  cells  share a large majority of  their  characteristic  anti‐
genic markers with other types of hematopoietic and mesenchymal cells (Bertolini et al.,
2006).  Therefore,  antigens  such  as  CD31,  CD34,  CD144  (VE-cadherin),  CD146,  Vwf  or
CD105 are  not  only  expressed by endothelial  cells  but  also  expressed by hematopoietic
cells  (specifically  HSCs),  platelets  and  certain  subpopulations  of  fibroblasts.  Hence  to
identify the differentiated and matured endothelial cells in the tubular scaffold a battery
of  various  early  and late  stage  vasculogenic  markers  such as  Pecam1,  CD34,  Flt1,  Flk1,
VE-cadherin,  fibronectin  and  Vwf  were  employed.  In  addition,  tomato  lectin,  another
marker specific for rat vascular endothelial cells,  was found closely associated with Flk1
and Vwf staining. These endothelial associated markers localized to endothelial cell clus‐
ters and capillary-like structures that were present throughout the tubular construct. This
suggests that BMSC-derived endothelial cells assembled into endothelium-lined tube-like
structures  and  initiated  the  process  of  vasculogenesis,  consistent  with  our  previous  re‐
port  (Figure  9  A-H) (Valarmathi  et  al.,  2008a).  In  addition,  the  BMSC-derived cells  and
the microvessel-like structures expressed the smooth muscle antigens, α-SMA and calpo‐
nin. These α-SMA positive cells were recruited in juxtaposition to the tandemly arranged
endothelial cells and, were attached and wrapped around in such a way that is reminis‐
cent of in vivo microvessel morphogenesis.
In order  to  quantitate  the degree of  vasculogenesis,  image morphometric  analyses  were
used to determine the capillary density, vessel breadth and length (integrated morphom‐
etry  subroutine  of  MetaMorph  6.1).  In  brief,  confocal  scanning  laser  microscopic  color
images were converted to 8-bit  monochrome images for both image and fractal  analysis
(Fuseler  et  al.,  2007;  Fernandez  et  al.,  2001;  Grizzi  et  al.,  2005;  Valarmathi  et  al.,  2012).
The fluorescence vasculature  in  an image was defined as  a  Region of  Interest  (ROI)  by
being  thresholded  using  the  “set  threshold”  subroutine  of  MetaMorph  Image  analysis
software  (v.6.1).  The  morphological  descriptors  of  fiber  breadth  were  a  representative
measure  of  blood  vessel  diameter.  Fiber  length  was  measured  using  the  integrated
morphometry algorithm of MetaMorph. Using this technique we were able to reconfirm
what our confocal images demonstrated. In microvascular media, the BMSC-derived mi‐
crovessels were longer (63%) and broader (37%) when compared with microvessels gen‐
erated in basal media (Figure 10).
Similarly, it is critically important to characterize the ultrastructural morphology of any
stem cells that are directed to differentiate into vascular lineage cells. Scanning electron mi‐
croscopic (SEM) analysis of the tubular constructs depicted the pattern of microvessel mor‐
phogenesis and maturity. These formed nascent capillary-like structures and elongated
tube-like structures revealed patent lumen-like structures, elucidating the vessel-maturation
(Figure 11). Besides, transmission electron microscopic (TEM) analysis (Hanaichi et al., 1986)
revealed elongated capillary-like structures lined by differentiating endothelial cells (Figure
12A). These cells showed electron dense bodies as well as numerous small pinocytotic vesi‐
cles adjacent to the endothelial cell membranes as well as in their cytoplasm (Figure 12B,
small black arrows). In addition these cells exhibited variously sized cell-cell junctions,
which have the appearance of typical in vivo endothelial tight junctions (Figure 12C-F).
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Figure 9. Expression pattern of vasculogenic markers α-SMA and tomato lectin (TL). Localization of BMSC-derived vas‐
cular progenitor cells on the collagen tube scaffold by confocal microscopy is seen in panels A, C, E, and G. The merged
images showing the actin cytoskeleton are shown in panels B, D,F, and H. Sections of a day 9 osteogenic tube culture
demonstrated nascent capillary-like structures positive for α-SMA (red, A). These elongated cord-like structures
showed strong colocalization of α-SMA and actin (merged, B). In the tubes nuclei appeared aligned (blue, DAPI). In
adjacent fields, abundant sheets of parallel oriented α-SMA positive cells were abutting the nascent vessel-like struc‐
tures (red, C). The merged image (D) shows actin and α-SMA in vessel-like structures that appear to be in different
planes with almost a perpendicular alignment with the underlying α-SMA positive cells (D). Similar sections of osteo‐
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genic cultured tubes illustrate the sprouting and branching tubular structures positive for the rat endothelial marker
tomato lectin (red, E-H). A plexus of arborizing endothelial cells was observed. These plexuses contained capillary-like
vessels lined with endothelial cells (red, G). Similarly in the merged panel, the apparent multilayered nature of the ves‐
sels was observed. However in these fields, the plexuses of endothelial cells were not in a perpendicular arrangement
but rather in a web-like orientation (merged, H). Figures C and D were projections representing 19 sections collected
at 2 μm intervals. Figures G and H were projections representing 32 sections collected at 9 μm intervals. Merged im‐
ages (A-H) (A-D, Scale bar 20 μm; E-H, Scale bar 50 μm). Adapted from Valarmathi et al., 2008a.
Figure 10. Morphometric analysis of microvessel-like structures generated in the walls of collagen-gel tubular con‐
structs in different culture media, viz., basal or microvascular medium.
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Figure 11. Scanning electron microscopic (SEM) analysis of tubular constructs. SEM analysis of day 28 tubular con‐
structs under both vasculogenic and non-vasculogenic culture conditions showed the typical cobblestone appearance
of differentiated endothelial cells (A, F), stratification and networking (B, G), and the presence of smooth-walled tube-
like structures with its attached smooth muscle cells and/or pericytes (black arrows, D, E, I, J). Multiple smooth muscle-
like cells were wrapping around these tube-like structures (black asterisks, Figure C-E, H-J). These cylindrical structures
revealed the presence of evolving patent lumens (white asterisks, C-E, H, J). Some of these luminal surfaces showed
the regular cobblestone arrangement of endothelial cells (white asterisks, C, D). Adapted from Valarmathi et al., 2009.
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Figure 12. Transmission electron microscopic (TEM) analysis of tubular constructs. TEM analysis of day 28 tubular con‐
structs under both vasculogenic and non-vasculogenic culture conditions showed a vessel-like structure containing
many small dense bodies within endothelial cells on either side of the lumen (A). Note the most obvious feature of
endothelial cells, the concentration of small vesicles (pinocytotic vesicles) adjacent to the endothelial cell membranes
(B, black arrows). The interdigitating endothelial cells showing junctional regions (C, E, inserts, lower magnification).
The typical adherent junction could be visualized between two overlapping endothelial cell processes (D, F, inserts,
higher magnification).
Research Directions in Tumor Angiogenesis282
Furthermore, the ability to identify endothelial cells based on their increased metabolism of
Ac-LDL was examined using Ac-LDL tagged with the fluorescent probe (Dil-Ac-LDL) (Voy‐
ta et al., 1984). BMSC-derived endothelial cells and the nascent capillary-like structures were
brilliantly fluorescent whereas the fluorescent intensity of smooth muscle cells/pericytes was
barely detectable as reported previously (Valarmathi et al., 2009). This suggests that the
formed endothelial cells were not only fully differentiated but also functionally competent
and matured (Figure 13A-J).
This behavior of BMSCs and their exhibition of vasculogenic differentiation potential can be
attributed to the nature of microenvironmental factors in this culture conditions. The pre‐
conditioned factors in the growth microenvironment rendered by the aligned type I collagen
fibers of the tubular scaffold and the soluble differentiating factors provided by the vasculo‐
genic and non-vasculogenic media may be behind the BMSC fate determination. Further
work is ongoing to determine whether our prevascularised tubular scaffolds can survive im‐
plantation into a tissue defect and is able to anastomose promptly with vascular sprouts em‐
anating from the host. Finally, our morphological, molecular, immunological and
biochemical data reveal the intrinsic vasculogenic differentiation potential of BMSCs under
appropriate 3-D environmental conditions.
Previously, it has been shown that mature vascular endothelium can give rise to smooth
muscle cell (SMC) via endothelial-mesenchymal transdifferentiation, coexpressing both en‐
dothelial and SMC-specific phenotypic markers (Frid et al., 2002). Recently, it has been show
that Flk1-expressing blast cells derived from embryonic stem cells can act as precursors that
can differentiate into both endothelial and mural cell populations of the vasculature (Yama‐
shita et al., 2000). In this study, clonal analyses revealed the bi-lineage potential of BMSCs,
suggesting that both endothelial and smooth muscle/pericytes could be derived from single
colonies. However, in general, BMSC-derived colonies are clonal or nearly clonal. The colo‐
nies of BMSCs resultant from a number of cells may represent co-existence of several sub‐
clones, each capable of differentiating into specific lineages. Hence, single cell-derived
colonies that are stably transfected with lineage specific markers are needed to gain more
meaningful insights and address the origin of both lineages.
Our results indicate that the 3-D tubular scaffold with its unique characteristics provides
a  favorable  microenvironment  that  permits  the  development  of  in  situ  microvascular
structures.  Moreover,  this  is  the  first  ever  documentation  that  explicitly  demonstrates
that adult  BMSCs under appropriate in vitro environmental  cues can be induced to un‐
dergo vasculogenic differentiation culminating in microvessel morphogenesis. Our model
recapitulates many aspects of  in vivo de novo vasculogenesis.  Thus,  this unique culture
system  provides  an  in  vitro  model  to  investigate  the  maturation  and  differentiation  of
BMSC-derived vascular  endothelial  and smooth muscle  cells  in  the  context  of  postnatal
vasculogenesis.  In addition,  it  allows us to elucidate various molecular mechanisms un‐
derlying the origin of both endothelial and smooth muscle cells and especially to gain a
deeper insight and validate the emerging concept of  ‘one cell  and two fates’  hypothesis
of vascular development (Yamashita et al., 2000).
3-D Microvascular Tissue Constructs for Exploring Concurrent Temporal and Spatial Regulation of…
http://dx.doi.org/10.5772/53118
283
Figure 13. Characterization of BMSC-derived endothelial cells by Dil-Ac-LDL uptake. BMSCs cultured in collagen-gel
tubular scaffolds in non-vasculogenic (mesenchymal stem cell growth medium, MSCGM) and vasculogenic (microvas‐
cular endothelial cell growth medium, EGMMV) culture conditions were incubated with 10 μg / ml of Dil-Ac-LDL for 4
to 6 hours. Confocal laser scanning microscopic analysis of sections of day 21 tubular scaffolds in MSC growth medium
revealed abundant punctate perinuclear bright red fluorescence of the differentiated and matured endothelial cells
(A-F). These labeled vascular cells were organized into a discrete cluster (A, B), assembled into tangled capillary-like
structures on top of a cluster (white asterisks, C, D) and, transformed into nascent linear and branching capillary-like
structures (white asterisks, E, F). Similarly, confocal laser scanning microscopic analysis of sections of day 21 tubular
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scaffolds in microvascular endothelial cell growth medium revealed typical abundant punctate perinuclear bright red
fluorescence of the differentiated and matured endothelial cells (G-J). These labeled vascular cells were organized into
small discrete clusters (G), self-organized into numerous small capillaries with a central lumen (white arrow, H), assem‐
bled into solid cord of cells (white arrow, I) and, transformed into tube-like structure with attempted lumen formation
(white arrows, J). Cells were also stained for nuclei (blue, DAPI) and fibrillar actin (green, Alexa® 488 phalloidin). Im‐
ages (A-B) show a projection representing 13 sections collected at 3.05 μm intervals (36.60 μm). Images (C-D) show a
projection representing 20 sections collected at 4.05 μm intervals (76.95 μm). Images (E-F) show a projection repre‐
senting 4 sections collected at 2.05 μm intervals (6.15 μm). Image (H) shows a projection representing 20 sections col‐
lected at 5 μm intervals (95.00 μm). Image (I) shows a projection representing 13 sections collected at 4 μm intervals
(48.00 μm). Image (J) shows a projection representing 22 sections collected at 5 μm intervals (105.00 μm). Merged
images (A-J). (A-J, scale bar 50 μm). Adapted from Valarmathi et al., 2009.
5. Conclusions
Here we report a unique 3-D culture system that recapitulates many aspects of postnatal de
novo vasculogenesis and angiogenesis. This is the first comprehensive report that evidently
demonstrates that BMSCs under appropriate in vitro environmental conditions can be in‐
duced to undergo vasculogenic differentiation culminating in microvessels. Since BMSCs
differentiated into both endothelial and smooth muscle cell lineages, this in vitro model sys‐
tem provides a tool for investigating the cellular and molecular origin of both vascular en‐
dothelial cells and smooth muscle cells. In addition, this system can potentially be harnessed
to develop in vitro engineering of microvascular trees, especially using autologous bone-
marrow-derived BMSCs for therapeutic purposes in regenerative medicine.
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